iX Biopharma Ltd. (SGX:42C)

Singapore · Delayed Price · Currency is SGD

0.5000

+0.0350 (7.53%)

At close: Oct 29, 2026

Revenue by Segment

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Specialty Pharmaceuticals	5.63M	7.07M	5.65M	5.35M	13.92M
Nutraceutical	1.69M	1.11M	508.00K	749.00K	617.00K
Inter-Segment Sales	-473.00K	-415.00K	-202.00K	-189.00K	-146.00K
Total	6.85M	7.77M	5.96M	5.91M	14.39M

Revenue by Geography

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Australia	3.78M	6.66M	5.47M	5.12M	1.37M
China	675.00K	647.00K	408.00K	579.00K	521.00K
United States of America	1.98M	140.00K	5.00K	95.00K	12.40M
Singapore and Others	416.00K	318.00K	81.00K	-	-
Singapore	-	-	-	117.00K	93.00K
Total	6.85M	7.77M	5.96M	5.91M	14.39M